Literature DB >> 12615369

Travel epidemiology--a global perspective.

Robert Steffen1, Chiara deBernardis, Ana Baños.   

Abstract

In order to have a rational approach to necessary preventive measures it is essential to know the health risks. The 80 million travellers each year with destinations in Africa, Asia, Latin America, Pacific Islands and remote areas in Eastern Europe are exposed to a broad range of pathogens that are rarely encountered at home. The risk depends on the degree of endemicity in the area visited, the duration of stay, the individual behaviour and the preventive measures taken. Travellers' diarrhoea (TD) is the most frequent ailment of visitors to countries with poor hygiene. The incidence rate is 25-90% in the first 2 weeks abroad. The risk of TD is far less in travellers originating in a high risk country, as some immunity develops. Malaria is an important risk for travellers going to endemic areas. Without chemoprophylaxis, the monthly incidence is high in some destinations, among them frequently visited tropical Africa where 80-95% of the infections are due to Plasmodium falciparum. The incidence rates are lower in most endemic areas of Asia and Latin America where Plasmodium vivax predominates. The risk is nil in all capital cities of South America and SE Asia, as well as in many frequently visited tourist destinations. The diseases preventable by immunization will be discussed in a separate paper (Vaccination priorities; page 175). Sexually transmitted diseases occur frequently, as some travellers (5% of Europeans) engage in casual sex, approximately half of them without being protected by a condom. The prevalence for HIV-infection, syphilis, gonorrhoea, etc. often exceeds 50% in prostitutes. In some European countries, a major proportion of heterosexuals with newly acquired HIV-infection have acquired it while abroad.

Entities:  

Mesh:

Year:  2003        PMID: 12615369     DOI: 10.1016/s0924-8579(02)00293-5

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  27 in total

1.  Pharmaceutical care model to assess the medication-related risks of travel.

Authors:  Ian M Heslop; Michelle Bellingan; Richard Speare; Beverley D Glass
Journal:  Int J Clin Pharm       Date:  2014-10-01

2.  Influenza-Like Illness in Travelers to the Developing World.

Authors:  Stuart Wood; Kalyani Telu; David Tribble; Anuradha Ganesan; Anjali Kunz; Mary Fairchok; Elizabeth Schnaubelt; Mark D Johnson; Ryan Maves; Jamie Fraser; Indrani Mitra; Tahaniyat Lalani; Heather C Yun
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

3.  Knowledge, awareness, and attitudes toward antibiotic use and antimicrobial resistance among Saudi population.

Authors:  Mohamed E El Zowalaty; Tatiana Belkina; Saleh A Bahashwan; Ahmed E El Zowalaty; Jurjen Duintjer Tebbens; Hassan A Abdel-Salam; Adel I Khalil; Safaa I Daghriry; Mona A Gahtani; Fatimah M Madkhaly; Nahed I Nohi; Rafaa H Khodari; Reem M Sharahili; Khlood A Dagreery; Mayisah Khormi; Sarah Abuo Habibah; Bayan A Medrba; Amal A Gahtani; Rasha Y Hifthi; Jameelah M Zaid; Arwa W Amshan; Alqasim A Alneami; Ayman Noreddin; Jiří Vlček
Journal:  Int J Clin Pharm       Date:  2016-08-29

4.  Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria.

Authors:  Chimere O Agomo; Wellington A Oyibo
Journal:  Infect Dis Poverty       Date:  2013-08-30       Impact factor: 4.520

5.  Analysis of the pediatric health information system database as a surveillance tool for travel-associated infectious diseases.

Authors:  Daniel Olson; Meghan Birkholz; James T Gaensbauer; Edwin J Asturias; James K Todd
Journal:  Am J Trop Med Hyg       Date:  2015-03-16       Impact factor: 2.345

Review 6.  Gnathostomiasis, another emerging imported disease.

Authors:  Joanna S Herman; Peter L Chiodini
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

7.  Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

8.  Antibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptor.

Authors:  J Salimian; Ah Salmanian; R Khalesi; M Mohseni; Sm Moazzeni
Journal:  Iran J Microbiol       Date:  2010-09

9.  Major variations in malaria exposure of travellers in rural areas: an entomological cohort study in western Côte d'Ivoire.

Authors:  Eve Orlandi-Pradines; Christophe Rogier; Bernard Koffi; Fanny Jarjaval; Melissa Bell; Vanessa Machault; Christophe Pons; Romain Girod; Jean-Paul Boutin; Frédéric Pagès
Journal:  Malar J       Date:  2009-07-28       Impact factor: 2.979

10.  Summary of recommendations for the prevention of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.